Synthesis and characterization of Ni(II), Cu(II) and Zn(II) complexes with new macrocyclic Schiff base ligands containing piperazine moiety

Keypour H., Arzhangi P., Rahpeyma N., Rezaeivala M., Elerman Y., Buyukgungord O., ...More

JOURNAL OF MOLECULAR STRUCTURE, vol.977, no.1-3, pp.6-11, 2010 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 977 Issue: 1-3
  • Publication Date: 2010
  • Doi Number: 10.1016/j.molstruc.2010.04.036
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.6-11
  • Keywords: Piperazine moiety, Macrocyclic Schiff base, Zinc(II) complex, X-ray crystal structure, Square-planar geometry, CRYSTAL-STRUCTURE, RUTHENIUM(II) COMPLEXES, METAL-COMPLEXES, SPECTROSCOPY, DERIVATIVES, CHEMISTRY, CO(II)
  • Ondokuz Mayıs University Affiliated: Yes


Two new macrocyclic Schiff base ligands L(1) and L(2) from [1 + 1] and 12 + 2] condensation reaction, respectively, have been obtained in a one-pot synthesis starting from 1,4-bis(2-formylphenyl)piperazine and 2,2-dimethyl-propylendiamine. Unfortunately, because of the low solubility of two products, we were unable to separate them effectively. Macrocyclic Schiff base complexes [NiL(1)](ClO(4))(2), [CuL(1)](ClO(4))(2) and [ZnL(1)](ClO(4))(2) were prepared from the reaction of a mixture of L(1) and L(2) in the presence of nickel(11), copper(II) and zinc(II) metal ions, respectively. In all cases, only [1 + 1] condensation products were obtained and no metal complexes were isolated with the L2 macrocycle. All of complexes have been characterized by elemental analysis, IR spectra, FAB-MS, conductivity measurements and in the case of Zn(II) complex by (1)H and (13)C NMR spectroscopy. Crystal structures of [Nil(1)][(ClO(4))(2) and [NiL(1)]ClO(4))(2) complexes have been also determined. The Ni(II) is coordinated to the ligand L(1) and L(1) by two nitrogen atoms of piperazine group and two nitrogen atoms of the imine groups, in a slightly distorted square-planar geometry. (C) 2010 Elsevier B.V. All rights reserved.